Pralatrexate (PDX) produces a high and durable complete response rate in patients with chemotherapy resistant T-cell lymphomasO. A. O'Connor,P. Hamlin,C. Moskowitz,C. Portlock,D. Sarasohn, O. Dumitrescu,E. Neylon, M. Patterson,A. Zelenetz,M. Saunders,P. Cagnoni,D. Mould,M. Fleisher,A. Califano,F. Sirotnak,S. HorwitzANNALS OF ONCOLOGY(2008)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要